Search Result "Anlotinib"
Anlotinib-Induced Hypertension: Current Concepts and Future Prospects
Journal: Current Pharmaceutical Design
Volume: 28 Issue: 3 Year: 2022 Page: 216-224
Author(s): Bing Lv,Jing Chen,Xiao-Liang Liu
A Pilot Study of Anlotinib as a Combination Treatment in AdvancedNasopharyngeal Carcinoma
Journal: Current Cancer Drug Targets
Volume: 24 Issue: 3 Year: 2024 Page: 319-327
Author(s):
The Efficacy and Safety of Anlotinib Alone and in Combination withOther Drugs in Previously Treated Advanced Thymic Epithelia Tumors: ARetrospective Analysis
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 18 Issue: 4 Year: 2023 Page: 528-537
Author(s):
Anlotinib Inhibits Proliferation and Induces Apoptosis in B-cell Acute LymphoblasticLeukemia by Targeting the BTK and AKT/mTOR Pathway
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 23 Issue: 12 Year: 2023 Page: 1397-1405
Author(s):
Effects and Mechanisms of Anlotinib and Dihydroartemisinin Combination Therapy in Ameliorating Malignant Biological Behavior of Gastric Cancer Cells
Journal: Current Pharmaceutical Biotechnology
Volume: 22 Issue: 4 Year: 2021 Page: 523-533
Author(s): Qiong Luo,Suyun Zhang,Donghuan Zhang,Rui Feng,Nan Li,Wujin Chen,Xiangqi Chen,Sheng Yang
Anlotinib Overcomes Multiple Drug Resistant Colorectal Cancer Cells via Inactivating PI3K/AKT Pathway
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 21 Issue: 15 Year: 2021 Page: 1987-1995
Author(s): Weilan Lan,Jinyan Zhao,Wujin Chen,Haixia Shang,Jun Peng,Jiumao Lin
Astragaloside IV Overcomes Anlotinib Resistance in Non-small Cell LungCancer through miR-181a-3p/UPR-ERAD Axis
Journal: Current Computer-Aided Drug Design
Volume: 20 Issue: 0 Year: 2024 Page: 1-11
Author(s):
Anlotinib Inhibits Cell Proliferation, Migration and Invasion via Suppression of c-Met Pathway and Activation of ERK1/2 Pathway in H446 Cells
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 21 Issue: 6 Year: 2021 Page: 747-755
Author(s): Xiali Tang,Ying Zheng,Demin Jiao,Jun Chen,Xibang Liu,Shan Xiong,Qingyong Chen
Primary Pulmonary Lymphoepithelioma-like Carcinoma: A Case Report UtilizingCamrelizumab and Anlotinib for Prolonged Survival
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 24 Issue: 12 Year: 2024 Page: 954-960
Author(s):
Silencing TRIM29 Sensitizes Non-small Cell Lung Cancer Cells toAnlotinib by Promoting Apoptosis via Binding RAD50
Journal: Current Cancer Drug Targets
Volume: 24 Issue: 4 Year: 2024 Page: 445-454
Author(s):